Showing 361 - 380 results of 100,785 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( 5 ((non decrease) OR (mean decrease)) ))', query time: 1.35s Refine Results
  1. 361
  2. 362
  3. 363
  4. 364

    MAP-2 decrease follows the early PSA-NCAM reduction induced by glutamate exposure. by María Fernanda Podestá (639243)

    Published 2014
    “…MAP-2 and PSA-NCAM immunoreactive areas are expressed as mean values (±SEM) of 20–30 neurons per experimental condition. ns, non-significant; *** P<0.001 between bars, non-parametric Mann-Whitney test. …”
  5. 365
  6. 366
  7. 367
  8. 368

    Postnatal CDPPB treatment decreased [<sup>11</sup>C]PBR accumulation in saline-exposed offspring, but not in offspring prenatally exposed to LPS. by Dany Arsenault (229311)

    Published 2015
    “…<p>Postnatal CDPPB treatment decreased the accumulation of [<sup>11</sup>C]PBR in the olfactory bulb, cerebellum, hippocampus, striatum, hypothalamus and the whole brain of the offspring prenatally exposed to saline solution (A). …”
  9. 369

    Twenty-four hour monitoring revealed increased interaction and decreased activity during daytime in <i>Cdkl5</i> -/Y mice. by Kosuke Okuda (5150393)

    Published 2018
    “…<p>(A) (i) Mean number of particles. <i>Cdkl5</i> -/Y mice spend significantly more time staying together compared to <i>Cdkl5</i> +/Y mice during daytime (p < 0.001), but not in the nighttime (p = 0.2436). …”
  10. 370
  11. 371

    Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients by Lucy Baldeón R. (674016)

    Published 2014
    “…We correlated outcomes to clinical parameters, including BMI, HbA1c and lipid state.</p><p>Results</p><p>The Ecuadorian non-diabetic controls appeared as overweight (BMI>25: patients 85%, controls 82.5%) and as dyslipidemic (hypercholesterolemia: patients 60.7%, controls 67.5%) as the patients.…”
  12. 372
  13. 373
  14. 374

    Decreased brain glucose uptake and glucose transporter expressions at early stage of female aging. by Fan Ding (302565)

    Published 2013
    “…<p>A. Representative FDG-microPET images showed an age-related decline in brain glucose uptake in nonTg brain, which was maximal between 6 and 9 months of age. …”
  15. 375
  16. 376
  17. 377
  18. 378
  19. 379
  20. 380

    Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

    Published 2015
    “…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”